Comparing ϵ-Aminocaproic Acid and Tranexamic Acid in Reducing Postoperative Transfusions in Total Knee Arthroplasty

Journal of Knee Surgery

Volumn 30, Issue 5, 2017, Pages 460-466

  Churchill, Jessica L ^a   Puca, Kathleen E ^b   Meyer, Elizabeth ^c   Carleton, Matthew ^d   Anderson, Michael J ^e,f  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^b BLOOD RESEARCH INSTITUTE   (United States)

^c ST LUKE S MEDICAL CENTER   (United States)

^d Aurora West Allis Medical Center   (United States)

^e Advanced Healthcare   (United States)

^f NONE   (United States)

Author keywords

blood transfusion; total joint arthroplasty; total knee arthroplasty; tranexamic acid; aminocaproic acid

Indexed keywords

AMINOCAPROIC ACID; HEMOGLOBIN; TRANEXAMIC ACID; ANTIFIBRINOLYTIC AGENT;

ADULT; ARTICLE; CONTROLLED STUDY; COST CONTROL; DEEP VEIN THROMBOSIS; DIAGNOSIS RELATED GROUP; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; ERYTHROCYTE TRANSFUSION; FEMALE; HEALTH CARE COST; HEALTH CARE SYSTEM; HOSPITAL READMISSION; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OBSERVATIONAL STUDY; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PERIOD; RETROSPECTIVE STUDY; TOTAL KNEE ARTHROPLASTY; AGED; BLOOD LOSS, SURGICAL; CLINICAL TRIAL; COMPARATIVE STUDY; ECONOMICS; KNEE REPLACEMENT; MULTICENTER STUDY;

AGED; AMINOCAPROIC ACID; ANTIFIBRINOLYTIC AGENTS; ARTHROPLASTY, REPLACEMENT, KNEE; BLOOD LOSS, SURGICAL; ERYTHROCYTE TRANSFUSION; FEMALE; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE HEMORRHAGE; RETROSPECTIVE STUDIES; TRANEXAMIC ACID;

EID: 84990215858     PISSN: 15388506     EISSN: 19382480     Source Type: Journal    
DOI: 10.1055/s-0036-1593362     Document Type: Article

References (19)

1. Ponnusamy K. E. Kim T. J. Khanuja H. S. Perioperative blood transfusions in orthopaedic surgery. J Bone Joint Surg Am: 2014; 96 21 1836 1844
2. Bierbaum B. E. Callaghan J. J. Galante J. O. Rubash H. E. Tooms R. E. Welch R. B. An analysis of blood management in patients having a total hip or knee arthroplasty. J Bone Joint Surg Am: 1999; 81 01 2 10
3. Hart A. Khalil J. A. Carli A. Huk O. Zukor D. Antoniou J. Blood transfusion in primary total hip and knee arthroplasty. Incidence, risk factors, and thirty-day complication rates. J Bone Joint Surg Am: 2014; 96 23 1945 1951
4. Chen A. F. Klatt B. A. Yazer M. H. Waters J. H. Blood utilization after primary total joint arthroplasty in a large hospital network. HSS J: 2013; 9 02 123 128
5. Nadeau R. P. Howard J. L. Naudie D. DR. Antifibrinolytic therapy for perioperative blood conservation in lower-extremity primary total joint arthroplasty. JBJS Rev: 2015; 3 06 e1
6. Kim T. K. Chang C. B. Koh I. J. Practical issues for the use of tranexamic acid in total knee arthroplasty: a systematic review. Knee Surg Sports Traumatol Arthrosc: 2014; 22 08 1849 1858
7. Gillette B. P. Maradit Kremers H. Duncan C. M., et al. Economic impact of tranexamic acid in healthy patients undergoing primary total hip and knee arthroplasty. J Arthroplasty: 2013; 28 (8, Suppl): 137 139
8. Vigna-Taglianti F. Basso L. Rolfo P., et al. Tranexamic acid for reducing blood transfusions in arthroplasty interventions: a cost-effective practice. Eur J Orthop Surg Traumatol: 2014; 24 04 545 551
9. Fingar K. R. Stocks C. Weiss A. J. Steiner C. A. Most Frequent Operating Room Procedures Performed in U.S. Hospitals, 2003-2012.HCUP Statistical Brief #186. December 2014. Available at: http://www.hcup-us.ahrq.gov/reports/statbriefs/sb186-Operating-Room-Procedures-United-States-2012.pdf. Accessed September 12, 2016.
10. 3M HIS APRTM-DRG. Classification Software-Overview. Available at: http://archive.ahrq.gov/professionals/quality-patient-safety/quality-resources/tools/mortality/Hughessumm.pdf. Accessed July 5, 2016
11. Kiridly D. N. Karkenny A. J. Hutzler L. H. Slover J. D. Iorio R. Bosco J. A. III. The effect of severity of disease on cost burden of 30-day readmissions following total joint arthroplasty (TJA). J Arthroplasty: 2014; 29 08 1545 1547
12. Chauhan S. Gharde P. Bisoi A. Kale S. Kiran U. A comparison of aminocaproic acid and tranexamic acid in adult cardiac surgery. Ann Card Anaesth: 2004; 7 01 40 43
13. Falana O. Patel G. Efficacy and safety of tranexamic acid versus ϵ-aminocaproic acid in cardiovascular surgery. Ann Pharmacother: 2014; 48 12 1563 1569
14. Makhija N. Sarupria A. Kumar Choudhary S. Das S. Lakshmy R. Kiran U. Comparison of epsilon aminocaproic acid and tranexamic Acid in thoracic aortic surgery: clinical efficacy and safety. J Cardiothorac Vasc Anesth: 2013; 27 06 1201 1207
15. Camarasa M. A. Ollé G. Serra-Prat M., et al. Efficacy of aminocaproic, tranexamic acids in the control of bleeding during total knee replacement: a randomized clinical trial. Br J Anaesth: 2006; 96 05 576 582
16. Tan J. Chen H. Liu Q. Chen C. Huang W. A meta-analysis of the effectiveness and safety of using tranexamic acid in primary unilateral total knee arthroplasty. J Surg Res: 2013; 184 02 880 887
17. Wei Z. Liu M. The effectiveness and safety of tranexamic acid in total hip or knee arthroplasty: a meta-analysis of 2720 cases. Transfus Med: 2015; 25 03 151 162
18. Duncan C. M. Gillette B. P. Jacob A. K. Sierra R. J. Sanchez-Sotelo J. Smith H. M. Venous thromboembolism and mortality associated with tranexamic acid use during total hip and knee arthroplasty. J Arthroplasty: 2015; 30 02 272 276
19. ClinicalTrials.gov. TXA vs. Amicar in Total Knee and Hip Arthroplasty. Available at: https://clinicaltrials.gov/ct2/show/NCT02030821. Accessed June 27, 2016